- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02863484
Cavernous Sinus Dissection and Bleeding in Meningiomas (OCS)
August 6, 2016 updated by: Ahmed Hegazy, Kasr El Aini Hospital
Dissection of the Outer Layer of the Lateral Wall of the Cavernous Sinus Decreases Bleeding as Compared to Direct Tumor Attack in Middle Fossa Meningiomas: A Randomized Controlled Trial
The blood loss will be compared in middle fossa meningiomas which will receive pealing of the outer layer of the lateral wall of the cavernous sinus and those which will not revive pealing before the dura is opened
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Cases with middle fossa meningiomas will be randomised to one of two surgical techniques.
The first technique will involve pealing of the outer layer of the lateral wall of the cavernous sinus before the dura is opened and the tumour attacked, and the second group of cases will be operated by a standard technique, where the tumour will be directly attacked with out pealing of the outer layer of the lateral wall of the cavernous sinus.
Blood loss will be monitored in each case by calculating the amount of blood in the suction container and subtracting it from the amount of fluids used for irrigation during surgery.
The number of cotton patties and dressings will be also counted with each case as well as the number of gauzes used.
The pre-operative complete blood picture will be documented particularly the haemoglobin , hematocrits and others.
The same lab data will be also monitored after surgery.
The amount of blood transfusion required will also be calculated in each case.
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ahmed A Hegazy, MD
- Phone Number: 01002155090
- Email: ahmed.hegazy@kasralainy.edu.eg
Study Contact Backup
- Name: Noha Asem, MD
- Phone Number: 01003657120
- Email: kasralainirec@yahoo.com
Study Locations
-
-
Greater Cairo
-
Cairo, Greater Cairo, Egypt, 11553
- Recruiting
- Kasralainy medical college, Cairo University
-
Contact:
- Ahmed Hegazy, MD
- Phone Number: 01002155090
- Email: ahmed.hegazy@kasralainy.edu.eg
-
Contact:
- Noha Asem, MD
- Phone Number: 01003657120
- Email: KASEALAINIREC@YAHOO.COM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Meningiomas of the middle cranial fossa
Exclusion Criteria:
- Meningiomas outside the middle cranial fossa
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional surgery intra-dural
This arm will be surgically operated by direct attack of the tumour after opening the dura
|
pealing of the outer layer of the cavernous sinus
|
Experimental: Pealing surgery extra-dural
This arm the pealing of the outer layer of the lateral wall of the cavernous sinus will be done before the dura is opened.
After the pealing is completed, the middle meningeal artery will be divided at the foramen spinosum.
Then, the dura will be opened and the tumour attacked.
|
pealing of the outer layer of the cavernous sinus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Amount of blood loss as estimated by cubic centimetres during surgery
Time Frame: three months
|
three months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Radically of surgery as estimated by post-operative tumour volume in cubic centimetres on post-operative MRI
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ahmed Hegazy, MD, Professor of neurosurgery, faculty of medicine, Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2016
Primary Completion (Anticipated)
September 1, 2016
Study Completion (Anticipated)
October 1, 2016
Study Registration Dates
First Submitted
August 1, 2016
First Submitted That Met QC Criteria
August 6, 2016
First Posted (Estimate)
August 11, 2016
Study Record Updates
Last Update Posted (Estimate)
August 11, 2016
Last Update Submitted That Met QC Criteria
August 6, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-44-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meningiomas of the Middle Cranial Fossa
-
Asir John SamuelCompletedThe Study Focuses to Find the Intrarater Reliability, Test-retest Reliability and Validity of 10 Meters Walk Test Among Middle School Going ChildrenIndia
-
National Cancer Institute (NCI)CompletedRecurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma... and other conditionsUnited States
-
Roswell Park Cancer InstituteCompletedRecurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the... and other conditionsUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedTongue Cancer | Recurrent Colon Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral... and other conditionsUnited States
-
Tianjin Medical University General HospitalRecruitingMultiple Sclerosis | Neuromyelitis Optica Spectrum Disorder | Demyelinating Diseases of the Central Nervous SystemChina
-
National Cancer Institute (NCI)CompletedRadiation Toxicity | Malignant Neoplasm | Adult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Mixed Glioma | Adult Oligodendroglioma | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the... and other conditionsUnited States
-
Xuanwu Hospital, BeijingRecruitingNeuromyelitis OpticaChina
-
Imcyse SAActive, not recruiting
-
Icahn School of Medicine at Mount SinaiGuthy Jackson Charitable FoundationCompleted
-
University of CalgaryTerminatedNeuromyelitis OpticaCanada
Clinical Trials on surgery
-
University of AarhusCompletedAcute Post Operative Pain | Chronic Postsurgical PainDenmark
-
International Study Group on Minimally Invasive...Fondazione CARIT; LOGIX S.r.l.Unknown
-
Peking Union Medical College HospitalCompletedPancreatic Neuroendocrine TumorsChina
-
Hospital Central de la Defensa Gómez UllaClinica Universidad de Navarra, Universidad de NavarraEnrolling by invitationRectal Cancer | PROM | Functional Bowel DisorderSpain
-
Sunnybrook Health Sciences CentreMcMaster University; Unity Health Toronto; University of Toronto; University of... and other collaboratorsCompleted
-
The Second Hospital of Shandong UniversityRecruitingLung Diseases | SurgeryChina
-
Federal University of São PauloUnknownObesity | LymphedemaBrazil
-
Shanghai Zhongshan HospitalUnknownCarcinoma, Pancreatic Ductal | Circulating Tumor CellsChina
-
The Christie NHS Foundation TrustUniversity of ManchesterRecruitingQuality of Life | Lung NeoplasmsUnited Kingdom
-
Spinal Surgery Clinic, SträngnäsCompletedLow Back Pain | Pelvic Pain